Breast cancer

Komen Closes Gaps with High-Quality Breast Support Every Step of the Way

Retrieved on: 
Wednesday, March 27, 2024
Diamond, Diagnosis, Disease, Caregiver, Community health, Patient, Cancer, Woman, Breast cancer, Genetic counseling, Courage, PCC, Birth control

DALLAS, March 27, 2024 /PRNewswire/ -- For many, the path to high-quality breast health care is complex and challenging even in the best circumstances. People from underresourced communities, especially women of color, encounter even more barriers to care as they make their way through a fragmented health care system.

Key Points: 
  • People from underresourced communities, especially women of color, encounter even more barriers to care as they make their way through a fragmented health care system.
  • Susan G. Komen® is committed to ensuring all people receive the support and high-quality care they need at every step of their breast health journey.
  • Here are the top 5 ways Komen's PCC navigators provide support throughout your breast health care experience:
    We provide information and educational resources about breast cancer screening and treatment options.
  • Dealing with a breast cancer diagnosis is tough, as is waiting on test results or finding the courage to support a loved one through it all.

Heroes Helping Heroes During National Kidney Month

Retrieved on: 
Tuesday, March 26, 2024
Friends, First responder, Kidney disease, Prostate cancer, Organ, First, Death, CDC, Breast cancer, Community, Transplant, Firefighter, NFFF, Pharmaceutical industry

EMMITSBURG, Md., March 26, 2024 /PRNewswire/ -- The National Fallen Firefighters Foundation, (NFFF) and its affiliate, the First Responder Center for Excellence (FRCE), are partnering with Kidneys for Communities to empower first responder communities across the country to help fallen firefighters' families and others in the firefighter community who are in need of a lifesaving kidney transplant.

Key Points: 
  • Expand Your Legacy —a campaign developed by NFFF/FRCE and the Knox Company to build awareness among firefighters about the life-changing impact of becoming a living kidney donor — is working with Kidneys for Communities, a national community-directed living kidney donation program, to facilitate living kidney donations that support fallen firefighters' families and members of the firefighting community who are battling end-stage kidney disease.
  • "It can be difficult to ask a stranger or even friends and family members to donate a kidney.
  • Meanwhile, the Organ Procurement and Transplantation Network reports that approximately 13 people die each day waiting for a kidney transplant.
  • We hope this program helps those first responders who need kidneys to receive one and that others can become more educated about becoming a living kidney donor."

Nucleus Genomics launches to bring whole-genome sequencing to the public

Retrieved on: 
Monday, March 25, 2024
Human Genome Project, WGS, Blood pressure, Genomics, Health, Certification, Informatics, Founders Fund, Genetic testing, Risk, Genetics, Human, PRS, DNA, Accreditation, Breast, CAP, Overalls, Facial muscles, Cancer, CLIA, Breast cancer, BRCA2, BMI, BRCA1

NEW YORK, March 25, 2024 /PRNewswire/ -- Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.

Key Points: 
  • Nucleus further personalizes these risk assessments by integrating personal and lifestyle factors into their analysis — such as age, cholesterol levels, blood pressure, and BMI.
  • Nucleus will also offer pre-orders for its premium clinical-grade whole-genome sequencing (WGS) service, in which a customer's entire set of DNA will be read and analyzed.
  • Nucleus is proud to sequence all customer samples in the U.S. on Illumina's NovaSeq X Plus, the sequencing company's newest and most innovative high-throughput sequencing instrument.
  • Working with Illumina, Nucleus is leveraging this latest sequencing technology to make WGS broadly accessible to power personalized healthcare.

Susan G. Komen® and Walgreens Mark 5 Years of Impact, Surpassing $37 Million in Cancer Support

Retrieved on: 
Monday, March 25, 2024
Health, Leukemia, Partnership, Patient, Research, Breast, Cancer, Equity, LLS, Social, Breast cancer, Nursing

CHICAGO, March 25, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization and Walgreens announced today another milestone in the transformative five-year collaboration that has not only propelled groundbreaking research in breast cancer but has also significantly expanded access to essential breast health and breast cancer services, support and resources.. Throughout this multi-year partnership, Walgreens has contributed nearly $38 million to Komen and the Leukemia & Lymphoma Society to advance research for challenging-to-treat cancers and promote equitable access to care.

Key Points: 
  • With Walgreens' support, Susan G. Komen began serving patients directly through Komen's Patient Care Center in 2020, providing services like patient navigation and financial assistance to breast cancer patients nationwide through a telehealth model.
  • During the February 2024 "Care in Your Corner" campaign, Walgreens' customers demonstrated their generosity through in-store donations, contributing more than $5.4 million.
  • This collective effort has not only provided vital funds but has also opened new avenues for Susan G. Komen to extend support to individuals impacted by breast cancer.
  • "This year marks the culmination of five years of donations to Susan G. Komen and the Leukemia and Lymphoma Society.

LILYSILK and NBCF Partner to Launch Caring Collection, Elevating Breast Cancer Support and Awareness

Retrieved on: 
Monday, March 25, 2024
HOPE, Woman, Partnership, Solidarity, Education, Symbolism, National Breast Cancer Foundation, Pink, Hope, Life, Collection, Breast cancer, Multimedia

From March 1, 2024, to June 30, 2025, LILYSILK pledges to contribute 50% of the gross retail sales from the LILYSILK X NBCF Caring Collection to NBCF, to help support those affected by breast cancer through early detection, education, and support services.

Key Points: 
  • From March 1, 2024, to June 30, 2025, LILYSILK pledges to contribute 50% of the gross retail sales from the LILYSILK X NBCF Caring Collection to NBCF, to help support those affected by breast cancer through early detection, education, and support services.
  • The Caring Collection features exquisite silk items designed to offer solace and support in everyday life.
  • The collection serves as a symbol of strength, unity, and hope so no one faces breast cancer alone.
  • "Last year LILYSILK donated over $43,000 of eye masks to our HOPE Kits that are given to women undergoing breast cancer treatment.

LILYSILK and NBCF Partner to Launch Caring Collection, Elevating Breast Cancer Support and Awareness

Retrieved on: 
Monday, March 25, 2024
HOPE, Woman, Partnership, Solidarity, Education, Symbolism, National Breast Cancer Foundation, Pink, Hope, Life, Collection, Breast cancer

From March 1, 2024, to June 30, 2025, LILYSILK pledges to contribute 50% of the gross retail sales from the LILYSILK X NBCF Caring Collection to NBCF, to help support those affected by breast cancer through early detection, education, and support services.

Key Points: 
  • From March 1, 2024, to June 30, 2025, LILYSILK pledges to contribute 50% of the gross retail sales from the LILYSILK X NBCF Caring Collection to NBCF, to help support those affected by breast cancer through early detection, education, and support services.
  • The Caring Collection features exquisite silk items designed to offer solace and support in everyday life.
  • The collection serves as a symbol of strength, unity, and hope so no one faces breast cancer alone.
  • "Last year LILYSILK donated over $43,000 of eye masks to our HOPE Kits that are given to women undergoing breast cancer treatment.

Cryoablation Highly Effective for Breast Cancer Patients with Large Tumors

Retrieved on: 
Saturday, March 23, 2024
Radiation, Breast cancer, Patient, Neoplasm, Research, Breast, Cancer, Society, Freezing, Woman, Cryoablation, Ice, Recurrence, Hypertension, Medical imaging

FAIRFAX, Va., March 23, 2024 /PRNewswire/ -- A minimally invasive technique that uses ice to freeze and destroy small, cancerous tumors has now been proven effective for breast cancer patients with large tumors, providing a new treatment path for those who are not candidates for surgery, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.

Key Points: 
  • "For patients who have larger tumors but can't undergo surgery, this approach could be more effective than the current standard of care for patients who are not surgical candidates," said Yolanda Bryce, M.D., an interventional radiologist at Memorial Sloan Kettering Cancer Center.
  • Cryoablation is a minimally invasive treatment that uses imaging guidance such as ultrasound or a computed tomography (CT) scan to locate tumors.
  • If the tumors do grow, patients can be treated with cryoablation multiple times to control growth.
  • Patients with tumors larger than 1.4 cm were treated with multiple probes (one probe placement for each centimeter of disease).

YASH Technologies Partners with Baheya Foundation to Transform Cancer Care in Egypt

Retrieved on: 
Friday, March 22, 2024
Growth, Partnership, SAP S/4HANA, Health care, SAP, Woman, Breast cancer, Health, Nursing

"We are on a momentous mission to revolutionize cancer care and provide women of Egypt holistic health and safety programs harnessing the power of community partnerships and advanced technologies," said Gilan Felfela, Board Member of Baheya Foundation.

Key Points: 
  • "We are on a momentous mission to revolutionize cancer care and provide women of Egypt holistic health and safety programs harnessing the power of community partnerships and advanced technologies," said Gilan Felfela, Board Member of Baheya Foundation.
  • "This transformative project with YASH and SAP will significantly elevate patient experiences at Baheya and provide us with accurate insights to optimize decision-making while driving operational efficiencies.
  • By meticulously catering to the unique requirements of the Baheya Foundation, YASH will help facilitate enhanced stability and growth in the healthcare group.
  • The Baheya Foundation is widely recognized for its dedication to providing exceptional patient care and implementing innovative programs.

YASH Technologies Partners with Baheya Foundation to Transform Cancer Care in Egypt

Retrieved on: 
Friday, March 22, 2024
Growth, Partnership, SAP S/4HANA, Health care, SAP, Woman, Breast cancer, Health, Nursing

"We are on a momentous mission to revolutionize cancer care and provide women of Egypt holistic health and safety programs harnessing the power of community partnerships and advanced technologies," said Gilan Felfela, Board Member of Baheya Foundation.

Key Points: 
  • "We are on a momentous mission to revolutionize cancer care and provide women of Egypt holistic health and safety programs harnessing the power of community partnerships and advanced technologies," said Gilan Felfela, Board Member of Baheya Foundation.
  • "This transformative project with YASH and SAP will significantly elevate patient experiences at Baheya and provide us with accurate insights to optimize decision-making while driving operational efficiencies.
  • By meticulously catering to the unique requirements of the Baheya Foundation, YASH will help facilitate enhanced stability and growth in the healthcare group.
  • The Baheya Foundation is widely recognized for its dedication to providing exceptional patient care and implementing innovative programs.

PreciseDx Presents New Research on Their AI-Enabled Digital Test at 14th Annual European Breast Conference

Retrieved on: 
Friday, March 22, 2024
Conference, Allianz, Risk, Patient, Research, Doctor of Philosophy, MD, Breast cancer, Recurrence, Artificial intelligence

NEW YORK, March 22, 2024 /PRNewswire-PRWeb/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease analysis, today announced their attendance and participation at the 14th Annual European Breast Conference in Milan, Italy. PreciseDx Co-Founder and Chief Medical Officer, Michael J. Donovan, PhD, MD is presenting the findings from the PreciseBreast™ biopsy clinical validation study through a poster presentation.

Key Points: 
  • "This study marks a notable milestone in oncology prognosis, reflecting the continued advancement of breast cancer research and treatment.
  • "This study marks a notable milestone in oncology prognosis, reflecting the continued advancement of breast cancer research and treatment.
  • "We look forward to sharing the outcomes of our breast biopsy clinical validation study with a diverse group of international, multidisciplinary conference attendees at the European Breast Cancer Conference."
  • The full poster presentation details can be found here:
    Location: Allianz MiCo (Milan Convention Centre), Milan, Italy
    The European Breast Cancer Conference, the first conference of its kind, started in 1998.